Literature DB >> 22614800

Risk factors for heterotopic ossification in patients with spinal cord injury: a case-control study of 264 patients.

Mustafa Citak1, Eduardo M Suero, Manuel Backhaus, Mirko Aach, Holger Godry, Renate Meindl, Thomas A Schildhauer.   

Abstract

STUDY
DESIGN: Case-control study.
OBJECTIVE: We designed a case-control study to analyze the risk factors associated with the development of heterotopic ossification (HO) in patients with traumatic spinal cord injury. SUMMARY OF BACKGROUND DATA: Patients with spinal cord injury have a high risk of developing HO, although the exact etiopathogenesis is still unknown. Several factors are known to be potential risk factors. However, we are not aware of any large clinical studies evaluating the risk factors for HO.
METHODS: Patients who were treated for a traumatic spinal cord injury in our hospital, and who subsequently developed HO, were identified by querying the electronic database at our hospital from 2002 to 2010. One hundred thirty-two patients and 132 controls were included. Our primary outcome measures were the risk of developing HO according to whether the patient had experienced a complete spinal cord lesion according to American Spinal Injury Association Impairment Scale; tetraplegia or paraplegia; cervical, thoracic, or lumbar injury; severe chest trauma; and the time interval between injury and surgery. Secondary risk factors explored were patient age; sex; presence and number of comorbidities; length of hospital and intensive care unit stay; associated traumatic injuries; presence of spasticity, pressure ulcers, deep venous thrombosis, and urinary tract infection; and pulmonary complications, such as pneumonia and necessity of tracheostomy.
RESULTS: Patients with associated spasticity and thoracic trauma, complete lesion, pneumonia, presence of tracheostomy, and urinary tract infection had a higher risk of developing HO.
CONCLUSION: Adequate management of potential risk factors could help reduce the overall incidence of HO and outcome in patients with traumatic spinal cord injury.

Entities:  

Mesh:

Year:  2012        PMID: 22614800     DOI: 10.1097/BRS.0b013e31825ee81b

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  21 in total

1.  Hyperphosphatemia in a patient with spinal cord injury who received etidronate for the treatment of heterotopic ossification.

Authors:  Sahil Taravati; Ece Cinar; Yesim Akkoc
Journal:  Spinal Cord Ser Cases       Date:  2017-06-08

Review 2.  Heterotopic Ossification Following Upper Extremity Injury.

Authors:  Shailesh Agarwal; Shawn Loder; Benjamin Levi
Journal:  Hand Clin       Date:  2017-05       Impact factor: 1.907

Review 3.  Vitamin D and spinal cord injury: should we care?

Authors:  J Lamarche; G Mailhot
Journal:  Spinal Cord       Date:  2016-09-20       Impact factor: 2.772

4.  Treatments that are perceived to be helpful for non-neuropathic pain after traumatic spinal cord injury: a multicenter cross-sectional survey.

Authors:  Chung-Ying Tsai; Thomas N Bryce; Andrew D Delgado; Sara Mulroy; Bria Maclntyre; Susan Charlifue; Elizabeth R Felix
Journal:  Spinal Cord       Date:  2021-03-19       Impact factor: 2.772

5.  Development of heterotopic ossifications, blood markers and outcome after radiation therapy in spinal cord injured patients.

Authors:  H Krauss; D Maier; V Bühren; F Högel
Journal:  Spinal Cord       Date:  2014-11-25       Impact factor: 2.772

6.  Ankylosing spondylitis does not increase the risk of neurogenic heterotopic ossification in patients with a spinal cord injury: a retrospective cohort study.

Authors:  M Ohlmeier; P Karras; E M Suero; D Grasmücke; M Aach; R Meindl; T A Schildhauer; M Citak
Journal:  Spinal Cord       Date:  2016-10-18       Impact factor: 2.772

7.  The sensitivity of ultrasound screening examination in detecting heterotopic ossification following spinal cord injury.

Authors:  T Rosteius; E M Suero; D Grasmücke; M Aach; A Gisevius; M Ohlmeier; R Meindl; T A Schildhauer; M Citak
Journal:  Spinal Cord       Date:  2016-06-28       Impact factor: 2.772

8.  Risk factors for the development of heterotopic ossification after knee dislocation.

Authors:  Daniel B Whelan; Andrew P Dold; Tomce Trajkovski; Jas Chahal
Journal:  Clin Orthop Relat Res       Date:  2014-09       Impact factor: 4.176

9.  The roles of serum alkaline and bone alkaline phosphatase levels in predicting heterotopic ossification following spinal cord injury.

Authors:  M Citak; D Grasmücke; E M Suero; O Cruciger; R Meindl; T A Schildhauer; M Aach
Journal:  Spinal Cord       Date:  2015-12-08       Impact factor: 2.772

10.  Association between alendronate, serum alkaline phosphatase level, and heterotopic ossification in individuals with spinal cord injury.

Authors:  Avraam Ploumis; Jayne M Donovan; Mobolaji O Olurinde; Dana M Clark; Jason C Wu; Douglas J Sohn; Kevin C O'Connor
Journal:  J Spinal Cord Med       Date:  2014-05-13       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.